83 related articles for article (PubMed ID: 9665501)
1. Is HIV infection a risk factor for advanced cervical cancer?
Fruchter RG; Maiman M; Arrastia CD; Matthews R; Gates EJ; Holcomb K
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Jul; 18(3):241-5. PubMed ID: 9665501
[TBL] [Abstract][Full Text] [Related]
2. The costs, clinical benefits, and cost-effectiveness of screening for cervical cancer in HIV-infected women.
Goldie SJ; Weinstein MC; Kuntz KM; Freedberg KA
Ann Intern Med; 1999 Jan; 130(2):97-107. PubMed ID: 10068381
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and correlates of cervical cancer screening among injection drug users.
McKnight B; McKnight I; Kerr T; Li K; Montaner J; Wood E
J Obstet Gynaecol Can; 2006 Aug; 28(8):695-699. PubMed ID: 17022909
[TBL] [Abstract][Full Text] [Related]
4. Unique human papillomavirus-type distribution in South African women with invasive cervical cancer and the effect of human immunodeficiency virus infection.
van Aardt MC; Dreyer G; Pienaar HF; Karlsen F; Hovland S; Richter KL; Becker P
Int J Gynecol Cancer; 2015 Jun; 25(5):919-25. PubMed ID: 25950128
[TBL] [Abstract][Full Text] [Related]
5. The relationship between HIV infection and cervical intraepithelial neoplasia among women attending two family planning clinics in Nairobi, Kenya.
Maggwa BN; Hunter DJ; Mbugua S; Tukei P; Mati JK
AIDS; 1993 May; 7(5):733-8. PubMed ID: 8318180
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus (HPV) infection, HIV infection and cervical cancer in Tanzania, east Africa.
ter Meulen J; Eberhardt HC; Luande J; Mgaya HN; Chang-Claude J; Mtiro H; Mhina M; Kashaija P; Ockert S; Yu X
Int J Cancer; 1992 Jun; 51(4):515-21. PubMed ID: 1318265
[TBL] [Abstract][Full Text] [Related]
7. A Study of Pap Smears in HIV-Positive and HIV-Negative Women from a Tertiary Care Center in South India.
Gupta K; Philipose CS; Rai S; Ramapuram J; Kaur G; Kini H; Gv C; Adiga D
Acta Cytol; 2019; 63(1):50-55. PubMed ID: 30721904
[TBL] [Abstract][Full Text] [Related]
8. Cervical dysplasia on cervicovaginal Papanicolaou smear among HIV-1-infected pregnant and nonpregnant women. Women and Infants Transmission Study.
Stratton P; Gupta P; Riester K; Fox H; Zorrilla C; Tuomala R; Eriksen N; Vajaranant M; Minkoff H; Fowler MG
J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Mar; 20(3):300-7. PubMed ID: 10077181
[TBL] [Abstract][Full Text] [Related]
9. Human immunodeficiency virus infection and invasive cervical cancer in South Africa.
Lomalisa P; Smith T; Guidozzi F
Gynecol Oncol; 2000 Jun; 77(3):460-3. PubMed ID: 10831360
[TBL] [Abstract][Full Text] [Related]
10. HIV infection increases the risk of squamous intra-epithelial lesions in women with HPV infection: an analysis of HPV genotypes. DIANAIDS Collaborative Study Group.
Cappiello G; Garbuglia AR; Salvi R; Rezza G; Giuliani M; Pezzotti P; Suligoi B; Branca M; Migliore G; Formigoni Pomponi D; D'Ubaldo C; Ippolito G; Giacomini G; Benedetto A
Int J Cancer; 1997 Sep; 72(6):982-6. PubMed ID: 9378562
[TBL] [Abstract][Full Text] [Related]
11. Integrating Cervical Cancer Screening with HIV Care in Cameroon: Comparative Risk Analysis of Cervical Disease in HIV-Infected Women Receiving Antiretroviral Therapy to Women in the General Population.
Bekolo CE; O'Bryan G; Tchago FE; Nangue C; Bekoule PS; Kollo B
PLoS One; 2016; 11(2):e0149152. PubMed ID: 26866371
[TBL] [Abstract][Full Text] [Related]
12. Cervical screening in HIV-positive women in the East of England: recent CD4 as the predictive risk factor.
Davies O; Rajamanoharan S; Balachandran T
Int J STD AIDS; 2015 Nov; 26(13):945-50. PubMed ID: 25505037
[TBL] [Abstract][Full Text] [Related]
13. Impact of HIV infection on invasive cervical cancer in Kenyan women.
Gichangi PB; Bwayo J; Estambale B; De Vuyst H; Ojwang S; Rogo K; Abwao H; Temmerman M
AIDS; 2003 Sep; 17(13):1963-8. PubMed ID: 12960829
[TBL] [Abstract][Full Text] [Related]
14. Limited impact of immunosuppression and HAART on the incidence of cervical squamous intraepithelial lesions in HIV-positive women.
Heard I; Potard V; Costagliola D
Antivir Ther; 2006; 11(8):1091-6. PubMed ID: 17302379
[TBL] [Abstract][Full Text] [Related]
15. Factors predicting the persistence of genital human papillomavirus infections and PAP smear abnormality in HIV-positive and HIV-negative women during prospective follow-up.
Branca M; Garbuglia AR; Benedetto A; Cappiello T; Leoncini L; Migliore G; Agarossi A; Syrjänen K;
Int J STD AIDS; 2003 Jun; 14(6):417-25. PubMed ID: 12816671
[TBL] [Abstract][Full Text] [Related]
16. Clinical and demographic predictors of late-stage cervical cancer.
Ferrante JM; Gonzalez EC; Roetzheim RG; Pal N; Woodard L
Arch Fam Med; 2000 May; 9(5):439-45. PubMed ID: 10810949
[TBL] [Abstract][Full Text] [Related]
17. Women with human immunodeficiency virus infection and abnormal Papanicolaou smears: a prospective study of colposcopy and clinical outcome.
Adachi A; Fleming I; Burk RD; Ho GY; Klein RS
Obstet Gynecol; 1993 Mar; 81(3):372-7. PubMed ID: 8437789
[TBL] [Abstract][Full Text] [Related]
18. [Cervical cancer: particularities in HIV patients].
Grellier N; Quéro L
Bull Cancer; 2014 Nov; 101(11):1040-7. PubMed ID: 25418597
[TBL] [Abstract][Full Text] [Related]
19. Association between HIV infection and cervical neoplasia: implications for clinical care of women at risk for both conditions.
Mandelblatt JS; Fahs M; Garibaldi K; Senie RT; Peterson HB
AIDS; 1992 Feb; 6(2):173-8. PubMed ID: 1558715
[TBL] [Abstract][Full Text] [Related]
20. Audit of cervical screening in women with HIV infection in the Auckland and Northland regions of New Zealand.
Grewal J; Lowe M; Gerrard H; Henley R; Perkins N; Briggs S
N Z Med J; 2010 Jul; 123(1319):71-8. PubMed ID: 20717179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
